BDC Capital invests $15 mln to grow STEMCELL Technologies
Vancouver-based biotechnology company STEMCELL Technologies Inc has secured $15 million in financing from BDC Capital’s Growth and Transition Capital division. Established in 1993 by Dr. Allen Eaves, the company's president and CEO, STEMCELL develops specialized reagents, tools and services supporting research in global cell biology and regenerative medicine. The funding partnership with BDC Capital will help STEMCELL continue to grow through expansion of its research and manufacturing facilities and development of new technologies and infrastructure to support its customer base of biomedical scientists.
12 February 2018•2 mins read
